Ruth D. Ellis

3.2k total citations
30 papers, 915 citations indexed

About

Ruth D. Ellis is a scholar working on Public Health, Environmental and Occupational Health, Immunology and Epidemiology. According to data from OpenAlex, Ruth D. Ellis has authored 30 papers receiving a total of 915 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Public Health, Environmental and Occupational Health, 10 papers in Immunology and 7 papers in Epidemiology. Recurrent topics in Ruth D. Ellis's work include Malaria Research and Control (17 papers), Mosquito-borne diseases and control (11 papers) and Complement system in diseases (6 papers). Ruth D. Ellis is often cited by papers focused on Malaria Research and Control (17 papers), Mosquito-borne diseases and control (11 papers) and Complement system in diseases (6 papers). Ruth D. Ellis collaborates with scholars based in United States, Mali and United Kingdom. Ruth D. Ellis's co-authors include Louis H. Miller, Kazutoyo Miura, Michael P. Fay, Gregory Mullen, Carole A. Long, Issaka Sagara, Ogobara K. Doumbo, C.J. Duncan, Anna P. Durbin and Daming Zhu and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Scientific Reports.

In The Last Decade

Ruth D. Ellis

30 papers receiving 895 citations

Peers

Ruth D. Ellis

PHEOH

IMMUN

EPIDE

Alioune Dièye Senegal

Arlene E. Dent United States

Léopold G. Lehman Cameroon

Ali Alloueche United Kingdom

Egeruan B. Imoukhuede United Kingdom

Dalma Maria Banic Brazil

George Nyangweso United Kingdom

Bright Adu Ghana

Didier Doumtabé Mali

Oscar Kai United Kingdom

Alioune Dièye Senegal

Ruth D. Ellis

492 ×1.0

PHEOH

277 ×0.7

IMMUN

134 ×0.6

126 ×0.7

147 ×0.9

EPIDE

Citations per year, relative to Ruth D. Ellis Ruth D. Ellis (= 1×) peers Alioune Dièye

Countries citing papers authored by Ruth D. Ellis

Since Specialization

Citations

This map shows the geographic impact of Ruth D. Ellis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth D. Ellis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth D. Ellis more than expected).

Fields of papers citing papers by Ruth D. Ellis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruth D. Ellis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth D. Ellis. The network helps show where Ruth D. Ellis may publish in the future.

Co-authorship network of co-authors of Ruth D. Ellis

This figure shows the co-authorship network connecting the top 25 collaborators of Ruth D. Ellis. A scholar is included among the top collaborators of Ruth D. Ellis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruth D. Ellis. Ruth D. Ellis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Penn‐Nicholson, Adam, Michèle Tameris, Erica Smit, et al.. (2018). Safety and immunogenicity of the novel tuberculosis vaccine ID93 + GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trial. The Lancet Respiratory Medicine. 6(4). 287–298. 114 indexed citations

Gonçalves, Bronner P., Issaka Sagara, Mamadou Coulibaly, et al.. (2017). Hemoglobin variants shape the distribution of malaria parasites in human populations and their transmission potential. Scientific Reports. 7(1). 14267–14267. 17 indexed citations

Ellis, Ruth D., Mark Hatherill, Dereck Tait, et al.. (2015). Innovative clinical trial designs to rationalize TB vaccine development. Tuberculosis. 95(3). 352–357. 23 indexed citations

Ellis, Ruth D., Yimin Wu, Donna Shaffer, et al.. (2012). Phase 1 Study in Malaria Naïve Adults of BSAM2/Alhydrogel®+CPG 7909, a Blood Stage Vaccine against P. falciparum Malaria. PLoS ONE. 7(10). e46094–e46094. 45 indexed citations

Guindo, Merepen A., et al.. (2012). Promoting Good Clinical Laboratory Practices and Laboratory Accreditation to Support Clinical Trials in Sub-Saharan Africa. American Journal of Tropical Medicine and Hygiene. 86(4). 573–579. 18 indexed citations

Duncan, C.J., Adrian V. S. Hill, & Ruth D. Ellis. (2012). Can growth inhibition assays (GIA) predict blood-stage malaria vaccine efficacy?. Human Vaccines & Immunotherapeutics. 8(6). 706–714. 52 indexed citations

Zhu, Daming, Elizabeth Gebregeorgis, Mary Anne Kidwell, et al.. (2011). Long term stability of a recombinant Plasmodium falciparum AMA1 malaria vaccine adjuvanted with Montanide® ISA 720 and stabilized with glycine. Vaccine. 29(20). 3640–3645. 7 indexed citations

Ellis, Ruth D., Michael P. Fay, Issaka Sagara, et al.. (2011). Anaemia in a phase 2 study of a blood stage falciparum malaria vaccine. Malaria Journal. 10(1). 13–13. 7 indexed citations

Miura, Kazutoyo, Hong Zhou, Joan Aebig, et al.. (2011). Non-Apical Membrane Antigen 1 (AMA1) IgGs from Malian Children Interfere with Functional Activity of AMA1 IgGs as Judged by Growth Inhibition Assay. PLoS ONE. 6(6). e20947–e20947. 10 indexed citations

10.

Ellis, Ruth D., Donna Shaffer, Carole A. Long, et al.. (2010). Phase 1 Trial of the Plasmodium falciparum Blood Stage Vaccine MSP142-C1/Alhydrogel with and without CPG 7909 in Malaria Naïve Adults. PLoS ONE. 5(1). e8787–e8787. 67 indexed citations

11.

Pierce, Mark A., Ruth D. Ellis, Elissa Malkin, et al.. (2010). Phase 1 safety and immunogenicity trial of the Plasmodium falciparum blood-stage malaria vaccine AMA1-C1/ISA 720 in Australian adults. Vaccine. 28(10). 2236–2242. 23 indexed citations

12.

Ellis, Ruth D., Issaka Sagara, Anna P. Durbin, et al.. (2010). Comparing the Understanding of Subjects Receiving a Candidate Malaria Vaccine in the United States and Mali. American Journal of Tropical Medicine and Hygiene. 83(4). 868–872. 9 indexed citations

13.

Ouattara, Amed, Shannon Takala‐Harrison, Rénion Saye, et al.. (2010). Lack of allele-specific efficacy of a bivalent AMA1 malaria vaccine. Malaria Journal. 9(1). 175–175. 48 indexed citations

14.

Ellis, Ruth D., Issaka Sagara, Ogobara K. Doumbo, & Yimin Wu. (2010). Blood stage vaccines forPlasmodium falciparum. Human Vaccines. 6(8). 627–634. 40 indexed citations

15.

Crompton, Peter D., Greta E. Weiss, Chiung‐Yu Huang, et al.. (2009). The TLR9 Ligand CpG Promotes the Acquisition of Plasmodium falciparum -Specific Memory B Cells in Malaria-Naive Individuals. The Journal of Immunology. 182(5). 3318–3326. 61 indexed citations

16.

Ellis, Ruth D., Gregory Mullen, Mark A. Pierce, et al.. (2009). A Phase 1 study of the blood-stage malaria vaccine candidate AMA1-C1/Alhydrogel® with CPG 7909, using two different formulations and dosing intervals. Vaccine. 27(31). 4104–4109. 45 indexed citations

17.

Mullen, Gregory, Ruth D. Ellis, Kazutoyo Miura, et al.. (2008). Phase 1 Trial of AMA1-C1/Alhydrogel plus CPG 7909: An Asexual Blood-Stage Vaccine for Plasmodium falciparum Malaria. PLoS ONE. 3(8). e2940–e2940. 85 indexed citations

18.

Dicko, Alassane, Issaka Sagara, Ruth D. Ellis, et al.. (2008). Phase 1 Study of a Combination AMA1 Blood Stage Malaria Vaccine in Malian Children. PLoS ONE. 3(2). e1563–e1563. 32 indexed citations

19.

Elstein, Arthur S., et al.. (1992). Hormonal Replacement Therapy. Medical Decision Making. 12(4). 265–273. 16 indexed citations

20.

Shichor, David & Ruth D. Ellis. (1981). Begging in Israel: An exploratory study. Deviant Behavior. 2(2). 109–125. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact